{"database":"ENA","file_versions":[],"scores":null,"additional":{"omics_type":["Genomics"],"center_name":["Medical University Vienna"],"full_dataset_link":["https://www.ebi.ac.uk/ena/browser/view/PRJNA1303036"],"long_description":["During the acute phase of COVID-19, elevated levels of several acute phase proteins, such as Creactive protein (CRP), mannose-binding lectin (MBL), pentraxin 3 (PTX-3), serum amyloid A (SAA) and surfactant protein D (SP-D), are associated with severe to fatal clinical outcomes.Typically, these markers return to baseline within days after resolution of the acute infection. In this study, we assessed these proteins in a well-defined cohort of 141 COVID-19 convalescent patients and looked for SNPs in the PTX-3 gene that could serve as biomarkers for the severness of the disease"],"repository":["ENA"],"additional_accession":[]},"is_claimable":false,"name":"","description":"Pentraxin 3 (PTX-3) and severness of COVID","dates":{"last_updated":"2025-09-16","first_public":"2025-09-16"},"accession":"PRJNA1303036","cross_references":{}}